The 'Research Safety Net' Saving Scientists from Funding Crisis

CDC Faces Critical Meetings Amid COVID Vaccine Uncertainty, Plus Deals, FDA Approvals, More

Lilly’s Obesity Pill Heads to the FDA, AbbVie Bets on Psychedelics, HHS Unveils More Change

Oral Weight-Loss Race Heats Up as New Data From Lilly, Viking Reset Expectations

Why AI Won't Save the 90% of Clinical Trials That Still Fail

MAHA Report Emphasizes Vaccines, Safety Vexes Viking’s Obesity Win, Novo Gains Momentum

The Hidden Patent Crisis That Could Break Biotech: What Every CEO Needs to Know

Prasad Returns, Delany Departs, Lilly’s Weight Loss Pill Disappoints and Sarepta’s Fallout Continues

From Chat Bots to World Order: The Race for the 21st Century's Operating System

FDA In Flux, Pfizer Talks to Trump on MFN, Merck Cuts 6K Jobs, More

We Don't Own Patient Data–We're Just Babysitting It

Sarepta Gets Reprieve, RFK Jr.’s New Changes, Roche’s Alzheimer’s Comeback and Q2 Earnings

Sarepta’s Wild Week, CDER’s New Leader, FDA Rejections, Manufacturing Billions

Why Countries Are Racing to Build mRNA Factories While America Hesitates on Next-Gen Vaccines

AI Is Taking Over Drug Safety Monitoring–But There's One Thing It Can't Replace

FDA Layoffs, 200 Rejection Letters, User Fees and Priority Vouchers, Bad Week for Rare Disease

Bonus Episode: Q2 2025 Job Market Update

The mRNA Revolution You Haven't Heard About: From Cystic Fibrosis to Personalized Cancer Vaccines

Second Half Milestones, KalVista’s Surprise Approval, Another RFK Jr. Lawsuit, More

CAR T Expands, M&A Ticks Up, Two Psychedelics Read Out, and the Supreme Court Rules on PrEP